Cargando…
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
Autores principales: | Epaulard, Olivier, Buisson, Marlyse, Nemoz, Benjamin, Maréchal, Marion Le, Terzi, Nicolas, Payen, Jean-François, Froidure, Marie, Blanc, Myriam, Mounayar, Anne-Laure, Quénard, Fanny, Pierre, Isabelle, Pavese, Patricia, Germi, Raphaele, Grossi, Laurence, Larrat, Sylvie, Poignard, Pascal, Lupo, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527702/ https://www.ncbi.nlm.nih.gov/pubmed/34687831 http://dx.doi.org/10.1016/j.jinf.2021.10.009 |
Ejemplares similares
-
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
por: Truffot, Aurélie, et al.
Publicado: (2021) -
Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
por: Jean-Pierre, Vincent, et al.
Publicado: (2021) -
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?
por: Andreani, Julien, et al.
Publicado: (2021) -
Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023) -
SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study
por: Landoas, A., et al.
Publicado: (2021)